Search Investor Relations

Investor Relations

We are a life sciences company committed to pushing science forward every day. Our Proteograph XT technology, equipped with engineered nanoparticles and automated workflows, unveils the proteome's complexity like never before, accelerating your research and discovery journey.

  • Dec 11, 2024 | 3:44 AM EST | Minimum 15 minutes delayed. Data Provided by Refinitiv.
  • See Stock Quote
Show all

Press Releases

Investor Events